EPO defers decision on appeal concerning BioPortoâ
Post# of 301275
Posted On: 10/15/2013 1:15:17 PM
EPO defers decision on appeal concerning BioPorto’s NGAL cutoff patent EP1831699
Following today’s hearing in the NGAL cutoff opposition proceedings, the European Patent Organization has exceptionally chosen not to reach a final decision. The proceedings will be continued on the basis of written submissions. BioPorto has not received information about the timing of further proceedings. BioPorto’s patent remains fully valid during the proceedings.
For further information, please contact:
Peter Mørch Eriksen, CEO
Christina Thomsen, Investor Relations Telephone +45 4529 0000, e-mail investor@bioporto.com
(0)
(0)